Tariq Sethi
Chief Tech/Sci/R&D Officer en ONCIMMUNE HOLDINGS PLC .
Perfil
Tariq Sethi is the founder of Galecto Biotech ApS and Galecto, Inc. both founded in 2011.
He is currently the Chief Scientific Officer at Oncimmune Holdings Plc since 2019.
Dr. Sethi's former positions include being a Professor at The University of Edinburgh, and Head of Respiratory Medicine at King's College London and King's Health Partners Ltd.
Cargos activos de Tariq Sethi
| Empresas | Cargo | Inicio |
|---|---|---|
| ONCIMMUNE HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 01/10/2019 |
Antiguos cargos conocidos de Tariq Sethi.
| Empresas | Cargo | Fin |
|---|---|---|
| GALECTO, INC. | Founder | - |
| The University of Edinburgh | Corporate Officer/Principal | - |
King's Health Partners Ltd.
 King's Health Partners Ltd. Miscellaneous Commercial ServicesCommercial Services King's Health Partners Ltd. operates as an academic health sciences center. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
| King's College London | Corporate Officer/Principal | - |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Founder | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ONCIMMUNE HOLDINGS PLC | Health Technology |
| GALECTO, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
King's Health Partners Ltd.
King's Health Partners Ltd. Miscellaneous Commercial ServicesCommercial Services King's Health Partners Ltd. operates as an academic health sciences center. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Commercial Services |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Tariq Sethi
